Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert A. Wood, MD
Department of Pediatrics at the Johns Hopkins University School of Medicine
Study Chair - Sharon Chinthrajah, MD
Department of Medicine, Stanford University School of Medicine
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arkansas Children'S Hospital Research Institute: Department of Pediatrics, Allergy & Immunology
Little Rock, Arkansas, United States
- Stanford School of Medicine: Sean N. Parker Center for Allergy & Asthma Research
Stanford, California, United States
- National Jewish Health: Division of Pediatric Allergy and Clinical Immunology
Denver, Colorado, United States
- Emory University School of Medicine: Children'S Healthcare of Atlanta Pediatrics
Atlanta, Georgia, United States
- Johns Hopkins Children'S Center: Department of Allergy & Immunology
Baltimore, Maryland, United States
- Massachusetts General Hospital, Department of Medicine: Allergy & Clinical Immunology Unit
Boston, Massachusetts, United States
- Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology
New York, New York, United States
- North Carolina Children'S Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology
Chapel Hill, North Carolina, United States
- Children'S Hospital of Philadelphia: Division of Allergy and Immunology
Philadelphia, Pennsylvania, United States
- University of Texas Southwestern Medical Center: Division of Allergy and Immunology
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Jul 2019
- Primary completion
- 13 Mar 2023
- Completion
- 1 Jul 2025
- Last update posted
- 10 Sept 2025
- Registered enrollment
- 471
- Registry id
- NCT03881696
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.